**Core Concept**
Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used primarily in the treatment of major depressive disorder. It is the active metabolite of venlafaxine, a commonly used antidepressant. The pharmacological mechanism of desvenlafaxine involves the inhibition of the reuptake of both serotonin and norepinephrine, thereby increasing their concentrations in the synaptic cleft.

**Why the Correct Answer is Right**
Desvenlafaxine specifically targets the serotonin and norepinephrine transporters, resulting in an increase in the levels of these neurotransmitters in the synaptic cleft. This action is thought to contribute to its antidepressant effects. The mechanism of action is similar to that of other SNRIs, such as venlafaxine, and is distinct from that of selective serotonin reuptake inhibitors (SSRIs).

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not provided, so we cannot evaluate it.
* **Option B:** This option is not provided, so we cannot evaluate it.
* **Option C:** This option is not provided, so we cannot evaluate it.
* **Option D:** This option is not provided, so we cannot evaluate it.

**Clinical Pearl / High-Yield Fact**
It's essential to note that desvenlafaxine has a relatively lower risk of dose-related side effects compared to its parent compound, venlafaxine. This is because desvenlafaxine has a more favorable pharmacokinetic profile, with a more predictable dose-response relationship.

**Correct Answer:**